The premise of this proposal is that innate immunity may be the only resource left in HIV-1 infected individuals progressing to AIDS to deal with opportunistic infections such as MDR or XDR Mycobacterium tuberculosis (MTB). Given the CD4+ T cell population and function breakdown in AIDS, and associated loss of adaptive immunity responses and pathogen control, we believe that we can nevertheless resort to autophagy as an innate immunity process to combat MTB in HIV-infected macrophages. In this project we will delineate the previously unappreciated but rapidly emerging links between innate immunity (specifically IL-1? and pattern recognition receptors) and autophagy as an antimicrobial effector mechanism. Autophagy has been shown by us and others to eliminate intracellular MTB. Currently, there are two standard ways of inducing autophagy: by starvation and by the immunosuppressant rapamycin. Here, we propose to delineate additional immunological methods of inducing autophagy, following up on our published work showing that innate immunity pattern recognition receptors (PRR), e.g. Toll-like receptors (TLR), control autophagy. Moreover, our preliminary studies show that IL-1? can induce autophagy. In this project, we will delineate pathways for innate immunity induction of antimicrobial autophagy to understand how these newly recognized processes work. These studies will provide a foundation for use of autophagy agonists in difficult cases such as drug resistant MTB in AIDS patients. Hypothesis: We hypothesize that innate immunity receptors and mediators, specifically pattern recognition receptors (PRR) and IL1-? receptor and their downstream signaling pathways induce autophagy as an antimycobacterial mechanism. We furthermore hypothesize that agonists of innate immunity receptors will, through autophagy, eliminate M. tuberculosis in HIV-coinfected macrophages, even in the absence of CD4+ T cells.
The specific aims are: 1. Determine how IL-1? induces autophagy as an antimycobacterial innate immunity effector. 2. Delineate how TLRs induce autophagy as an antimycobacterial defense. 3. Define factors of MTB elimination by PRR-induced autophagy in HIV infected macrophages.

Public Health Relevance

We have very few resources left in AIDS to deal with dangerous infections such as MDR or XDR Mycobacterium tuberculosis. The leukocytes that normally wall off M. tuberculosis in immunologically competent people are absent or are dysfunctional in AIDS. However, there are parts of immunity called innate immunity that are relatively intact in HIV infected people, but have been thus far untapped in combating tuberculosis in AIDS. We have pioneered studies of a new innate immunity process called autophagy, whereby cells can digest portions of their cytoplasm and similarly digest unwanted microbes (such as M. tuberculosis) lodged in their interiors. The present project is aimed at connecting cell surface receptors on macrophages (the cell type in which M. tuberculosis hides) and autophagy. We wish, by stimulating such surface receptors, to enable the macrophage to digest the unwanted M. tuberculosis that it unwittingly harbors and cannot get rid of in the absence of helper lymphocytes, as happens in HIV infected individuals when they progress to AIDS. Our project will lead to novel treatments of difficult cases such as drug resistant MTB in AIDS patients.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI042999-15
Application #
8278672
Study Section
AIDS-associated Opportunistic Infections and Cancer Study Section (AOIC)
Program Officer
Parker, Tina M
Project Start
1998-04-01
Project End
2014-05-21
Budget Start
2012-06-01
Budget End
2013-05-31
Support Year
15
Fiscal Year
2012
Total Cost
$498,578
Indirect Cost
$166,772
Name
University of New Mexico
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
868853094
City
Albuquerque
State
NM
Country
United States
Zip Code
87131
Klionsky, Daniel J; Eskelinen, Eeva-Liisa; Deretic, Vojo (2014) Autophagosomes, phagosomes, autolysosomes, phagolysosomes, autophagolysosomes... wait, I'm confused. Autophagy 10:549-51
Dupont, Nicolas; Chauhan, Santosh; Arko-Mensah, John et al. (2014) Neutral lipid stores and lipase PNPLA5 contribute to autophagosome biogenesis. Curr Biol 24:609-20
Deretic, Vojo (2014) Autophagy in tuberculosis. Cold Spring Harb Perspect Med 4:a018481
Mandell, Michael A; Jain, Ashish; Arko-Mensah, John et al. (2014) TRIM proteins regulate autophagy and can target autophagic substrates by direct recognition. Dev Cell 30:394-409
Deretic, Vojo; Saitoh, Tatsuya; Akira, Shizuo (2013) Autophagy in infection, inflammation and immunity. Nat Rev Immunol 13:722-37
Dokladny, Karol; Zuhl, Micah Nathaniel; Mandell, Michael et al. (2013) Regulatory coordination between two major intracellular homeostatic systems: heat shock response and autophagy. J Biol Chem 288:14959-72
Jiang, Shanya; Dupont, Nicolas; Castillo, Eliseo F et al. (2013) Secretory versus degradative autophagy: unconventional secretion of inflammatory mediators. J Innate Immun 5:471-9
Bradfute, Steven B; Castillo, Eliseo F; Arko-Mensah, John et al. (2013) Autophagy as an immune effector against tuberculosis. Curr Opin Microbiol 16:355-65
Deretic, Vojo (2012) Autophagy as an innate immunity paradigm: expanding the scope and repertoire of pattern recognition receptors. Curr Opin Immunol 24:21-31
Korolchuk, Viktor I; Saiki, Shinji; Lichtenberg, Maike et al. (2011) Lysosomal positioning coordinates cellular nutrient responses. Nat Cell Biol 13:453-60

Showing the most recent 10 out of 54 publications